In re Protegrity Corp. & Protegrity USA, Inc.

84 F. Supp. 3d 1380, 2015 U.S. Dist. LEXIS 14291, 2015 WL 506373
United States Judicial Panel on Multidistrict Litigation·Decided February 6, 2015·No. MDL No. 2600·Published

Opinion

TRANSFER ORDER

SARAH S. VANCE, Chair.

Before the Panel:* Patentholders Pro-tegrity Corp. and Protegrity USA, Inc., (collectively Protegrity) move under 28 U.S.C. § 1407 to centralize pretrial proceedings in this patent litigation in the District of Connecticut. Protegrity seeks centralization only for coordinated or consolidated Markman hearings. This litigation consists of seventeen actions, pending in six districts, as listed on Schedule A.1

The parties’ positions on Protegrity’s motion vary. Nine accused infringers 2 oppose centralization and, alternatively suggest that we select the Northern District of California as the transferee district. Two accused infringers (TokenEx, LLC and AJB Software Design, Inc.) take no position on centralization, but if the actions are centralized, they suggest selecting the Northern District of California as the transferee district. Finally, three accused infringers (Trustwave Holdings, Inc., Per-specSys USA, Inc., and Epicor Software Corp.) support centralization in either the District of Connecticut or the Northern District of California, but only if the litigation is not stayed pending potential Covered Business Patent review by the Patent Trial and Appeal Board.3

[1381] At issue in this litigation are two patents owned by Protegrity: U.S. Patent Nos. 6,321,201 ('201 patent) and 8,402,281 ('281 patent). The patents relate to a method and apparatus for protecting data within databases.

On the basis of the papers filed and hearing session held, we find that these seventeen actions involve common questions of fact, and that centralization in the Northern District of California will serve the convenience of the parties and witnesses and promote the just and efficient conduct of the litigation. All actions involve factual questions about the alleged infringement, validity and enforceability of the '201 and '281 patents. Centralization will eliminate duplicative discovery and prevent inconsistent pretrial rulings (particularly on issues of staying the litigation during possible Covered Business Patent review, claim construction and whether the patents involve unpatentable subject matter), as well as conserve the resources of the parties, their counsel and the judiciary.

The accused infringers that oppose centralization offer several arguments against centralization, all of which fail to convince us that centralization of this litigation is inappropriate. These parties argue that: centralization is premature because infringement contentions have not been exchanged in certain actions, the actions involve different accused infringing products and. thus differing fact questions, and efficiency will not be served by centralization^ given the pendency of certain dispositive motions. While infringement contentions have not been exchanged in most actions, Protegrity asserts that independent claims in the '201 patent (Claims 1 and 8) and - '281 patent (Claims 1, 17, 33, and 47) will be the primary focus of the litigation. That the actions involve differing accused infringing products has not been an impediment to centralization in past litigation involving common patents.4 Further, centralization will eliminate the potential for inconsistent rulings on several pending motions to dismiss willful or indirect infringement allegations and the two pending motions to dismiss based on unpatentable subject matter.

The opponents of centralization also argue that the history of settlements of these actions involving the Protegrity patents weighs in favor of denying centralization, citing our decision -in In re: ArrivalStar Patent Litigation, 802 F.Supp.2d 1378 (J.P.M.L.2011). In re: ArrivalStar is [1382] readily distinguishable from this litigation, as the patentholder opposed centralization and noted that it had “brought nearly 100 actions since it began bringing infringement suits in various districts across the country approximately seven years ago, and none of the actions thus far appear to have required significant judicial attention.” Id. at 1379. Here, Protegrity spent years litigating against several defendants in the District of Connecticut. These now-closed cases needed significant judicial attention to address issues of claim construction and attacks on patent validity and required the appointment of a technical advisor at substantial cost to the parties. One of the prior actions even proceeded through the first week of trial.

We deny Protegrity’s request to limit the centralized proceedings to claim construction. Our typical approach has been to decline to dictate the particular manner or course that pretrial proceedings should take. See, e.g., In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Pat. Litig., 657 F.Supp.2d 1375, 1376 (J.P.M.L.2009) (“Our decision to centralize these actions in no way dictates or even suggests the particular manner or course of such proceedings; consistent with our typical practice, we leave those determinations to the transferee judge.”). As Pro-tegrity has failed to provide us with a good reason to deviate from this approach, we dedicate the determination of the exact structure of the MDL proceedings to the sound judgment of transferee judge.

We are of the view that the Northern District of California is the most appropriate transferee district for pretrial proceedings in this litigation. Several accused infringers are located in or near this district. Further, the Northern District of California is a Patent Pilot Program Court that has adopted local Patent Rules, and the district is highly familiar with complex technological patent litigation.

IT IS THEREFORE ORDERED that the actions listed on Schedule A and pending outside the Northern District of Cali-fornia are transferred to the Northern District of California and, with the consent of that court, assigned to the Honorable James Donato for coordinated or consolidated pretrial proceedings.

SCHEDULE A

MDL No. 2600 — IN RE: PROTEGRITY CORPORATION AND PROTEGRITY USA, INC., PATENT LITIGATION

Northern District of California

PROTEGRITY CORP. v. INFORMATICA CORP., C.A. No. 3:14 02588

SKYHIGH NETWORKS, INC. v. PROTEGRITY CORP., C.A. No. 3:14 03151

SQUARE, INC. v. PROTEGRITY CORP., C.A. No. 3:14 03423

PROTEGRITY CORP. v. DATAGUISE, INC., C.A. No. 3:14 04283

Southern District of California

IPS GROUP, INC. v. PROTEGRITY CORP., C.A. No. 3:14 00075

District of Connecticut

PROTEGRITY CORP. v. PERSPECSYS USA INC., C.A. No. 3:13-01383

PROTEGRITY CORP. v. PRIME FACTORS, INC., C.A. No. 3:13 01384

PROTEGRITY CORP. v. TRUSTWAVE HOLDINGS, INC., C.A. No. 3:13 01409

PROTEGRITY CORP. v. AJB SOFTWARE DESIGN, INC., C.A. No. 3:13 01484

[1383] PROTEGRITY CORP. v. EPICOR SOFTWARE CORP., C.A. No. 3:13 01781

Free access — add to your briefcase to read the full text and ask questions with AI

In re Protegrity Corp. & Protegrity USA, Inc., 84 F. Supp. 3d 1380, 2015 U.S. Dist. LEXIS 14291, 2015 WL 506373 (jpml 2015).

84 F. Supp. 3d 1380 (In re Protegrity Corp. & Protegrity USA, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In Re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation
657 F. Supp. 2d 1375 (Judicial Panel on Multidistrict Litigation, 2009)
In re Arrivalstar S.A. Fleet Management Systems Patent Litigation
802 F. Supp. 2d 1378 (Judicial Panel on Multidistrict Litigation, 2011)
In re Bear Creek Technologies, Inc., ('722) Patent Litigation
858 F. Supp. 2d 1375 (Judicial Panel on Multidistrict Litigation, 2012)